Clinical Trials Logo
  1. Home
  2. Coronavirus Infections
  3. NCT05303155
  4. Details
NCT05303155 Clinical Trial

The Association of Gut Microbiota With COVID 19 Infection in Children

Coronavirus Infections Clinical Trial

Official title:
The Association of Gut Microbiota With Early Infection Stages of COVID-19 in Children

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05303155
Other study ID # Covid 19 and Gut Microbiota
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 14, 2022
Est. completion date December 31, 2024

Study information
Verified date May 2023
Source Hallym University Kangnam Sacred Heart Hospital
Contact KY YOUNG CHO, MD, PhD
Phone 821090910197
Email choky96@naver.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Although COVID-19 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. The investigators will analyze the alterations in fecal microbiomes of patients with COVID-19 infection during hospitalization.

Recruitment information / eligibility
Status Recruiting
Enrollment 40
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Months to 15 Years
Eligibility Inclusion Criteria: - patients infected with COVID 19 Exclusion Criteria: - congenital heart, renal, intestinal disease - malignancy - immunologic disease

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• 16S rRNA sequencing
Fecal microbiome analysis using 16S rRNA sequencing

Locations
Country Name City State
Korea, Republic of Hallym University Kangnam Sacred Heart Hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Hallym University Kangnam Sacred Heart Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary The analysis of fecal microbiome of patient with COVID 19 The analysis of fecal microbiome of patient with COVID 19, using 16S rRNA sequencing through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT04553575 - CoViD-19 Patient in Reims University Hospital in March to April 2020
Active, not recruiting NCT05033847 - Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above Phase 2
Active, not recruiting NCT05548439 - Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a Phase 1
Completed NCT05046548 - This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 Phase 1/Phase 2
Active, not recruiting NCT05726084 - Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older Phase 2/Phase 3
Recruiting NCT05069129 - Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above Phase 1/Phase 2
Enrolling by invitation NCT05054075 - Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Phase 2
Recruiting NCT05599516 - Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial Phase 3
Completed NCT05047900 - The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community N/A
Completed NCT04420286 - Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
Completed NCT04424355 - Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.
Completed NCT05083039 - Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
Terminated NCT04409873 - Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) Phase 2
Enrolling by invitation NCT04327349 - Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial N/A
Completed NCT04321278 - Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) Phase 3
Recruiting NCT04327570 - In-depth Immunological Investigation of COVID-19.
Completed NCT04326309 - Audio Data Collection for Identification and Classification of Coughing
Recruiting NCT04322344 - Escin in Patients With Covid-19 Infection Phase 2/Phase 3
Completed NCT04323592 - Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
Completed NCT04328129 - Household Transmission Investigation Study for COVID-19 in Tropical Regions N/A